Inside-Filings
Projekt anfragen

Viatris Inc (VTRS)

Sentiment-Signal

33,5
Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
47.5
0 neu, 1 erhöht, -9721030K $ netto
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)

Score-Verlauf (90 Tage)

Stammdaten

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as offers biosimilars franchises, including Fulphila, Ogivri, Hulio, and SEMGLEE. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

Unternehmen & Branche

NameViatris Inc
TickerVTRS
CIK0001792044
BoerseUS
SektorHealthcare
IndustrieDrug Manufacturers - Specialty & Generic
SIC2834 · Pharmaceutical Preparations

Wertpapier & Kennzahlen

CUSIP001792044
ISINUS0017920440
TypCommon Stock
Marktkapitalisierung17,37 Mrd. USD
Beta0,82
Dividendenrendite0,48 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2025-12-3110-K14,299,900,000-3.0037,193,100,000
2025-09-3010-Q3,759,900,000-0.1137,920,400,000
2025-06-3010-Q3,582,100,0000.0038,411,500,000
2025-03-3110-Q3,254,300,000-2.5538,474,900,000
2024-12-3110-K14,739,300,000-0.5341,500,900,000
2024-09-3010-Q3,751,200,0000.0844,754,100,000
2024-06-3010-Q3,796,600,000-0.2745,330,000,000
2024-03-3110-Q3,663,400,0000.0947,343,700,000
2023-12-3110-K15,426,900,0000.0547,685,500,000
2023-09-3010-Q3,941,900,0000.2748,742,600,000
2023-06-3010-Q3,918,600,0000.2248,695,200,000
2023-03-3110-Q3,729,100,0000.1949,290,200,000
2022-12-3110-K16,262,700,0001.7150,022,200,000
2022-09-3010-Q4,078,200,0000.2948,662,600,000
2022-06-3010-Q4,116,800,0000.2651,125,100,000
2022-03-3110-Q4,191,700,0000.3353,466,900,000
2021-12-3110-K17,886,300,000-1.0554,842,800,000
2021-09-3010-Q4,536,600,0000.2656,070,400,000
2021-06-3010-Q4,577,800,000-0.2357,984,100,000
2021-03-3110-Q4,430,300,000-0.8658,979,200,000

Fondsaktivität (Vorquartalsvergleich)

FondsAktuell (Stk)Vorquartal (Stk)Veränderung (Stk)Wert (USD)StatusΔTrend
VANGUARD GROUP INC138,179,8640138,179,8641,720,339,307Neu+100,0%
BlackRock, Inc.86,824,817086,824,8171,080,968,975Neu+100,0%
DAVIS SELECTED ADVISERS78,177,984078,177,984973,315,913Neu+100,0%
STATE STREET CORP55,310,153055,310,153688,611,405Neu+100,0%
DIMENSIONAL FUND ADVISORS LP40,026,301040,026,301498,335,885Neu+100,0%
GEODE CAPITAL MANAGEMENT, LLC31,106,924031,106,924386,628,204Neu+100,0%
AMERIPRISE FINANCIAL INC26,845,389026,845,389334,225,093Neu+100,0%
Rubric Capital Management LP25,500,000025,500,000317,475,000Neu+100,0%
Invesco Ltd.23,326,114023,326,114290,410,125Neu+100,0%
MORGAN STANLEY16,179,967016,179,967201,440,606Neu+100,0%
FMR LLC15,106,058015,106,058188,070,426Neu+100,0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC13,496,292013,496,292168,028,839Neu+100,0%
NORTHERN TRUST CORP10,363,762010,363,762129,028,837Neu+100,0%
Callodine Capital Management, LP9,680,73609,680,736120,525,163Neu+100,0%
CITADEL ADVISORS LLC8,971,48308,971,483111,694,964Neu+100,0%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP8,661,73008,661,730107,838,539Neu+100,0%
BANK OF AMERICA CORP /DE/8,489,21208,489,212105,690,688Neu+100,0%
NORGES BANK6,432,84106,432,84180,088,870Neu+100,0%
GOLDMAN SACHS GROUP INC6,120,09306,120,09376,195,155Neu+100,0%
MILLENNIUM MANAGEMENT LLC6,067,12406,067,12475,535,694Neu+100,0%
D. E. Shaw & Co., Inc.6,042,85906,042,85975,233,594Neu+100,0%
JANE STREET GROUP, LLC5,463,84305,463,84368,024,845Neu+100,0%
BARCLAYS PLC5,427,86505,427,86567,576,916Neu+100,0%
Brandywine Global Investment Management, LLC5,423,97605,423,97667,528,501Neu+100,0%
AQR CAPITAL MANAGEMENT LLC5,043,99805,043,99862,797,775Neu+100,0%
Nantahala Capital Management, LLC5,000,00005,000,00062,250,000Neu+100,0%
JPMORGAN CHASE & CO4,929,01704,929,01761,366,273Neu+100,0%
DEUTSCHE BANK AG\4,262,88504,262,88553,072,919Neu+100,0%
AMERICAN CENTURY COMPANIES INC4,032,79404,032,79450,208,292Neu+100,0%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC3,834,35503,834,35547,737,720Neu+100,0%
Legal & General Group Plc3,585,64803,585,64844,641,315Neu+100,0%
Assenagon Asset Management S.A.3,574,68403,574,68444,504,816Neu+100,0%
VICTORY CAPITAL MANAGEMENT INC3,399,17703,399,17742,319,754Neu+100,0%
CITIGROUP INC3,162,03503,162,03539,367,337Neu+100,0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP2,961,39502,961,39536,869,368Neu+100,0%
TORONTO DOMINION BANK2,824,05102,824,05135,159,765Neu+100,0%
SEI INVESTMENTS CO2,788,73302,788,73334,719,520Neu+100,0%
FIL Ltd2,696,32202,696,32233,569,209Neu+100,0%
WEDGE CAPITAL MANAGEMENT L L P/NC2,678,20102,678,20133,343,602Neu+100,0%
ROYAL BANK OF CANADA2,430,11002,430,11030,254,000Neu+100,0%
Pictet Asset Management Holding SA2,360,11102,360,11129,213,914Neu+100,0%
Monaco Asset Management SAM2,330,29502,330,29529,012,173Neu+100,0%
Swiss National Bank2,298,80202,298,80228,620,085Neu+100,0%
BNP PARIBAS FINANCIAL MARKETS2,191,44702,191,44728,569,065Neu+100,0%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM2,153,80002,153,80026,814,810Neu+100,0%
RHUMBLINE ADVISERS1,989,28401,989,28424,766,508Neu+100,0%
Squarepoint Ops LLC1,979,37101,979,37124,643,169Neu+100,0%
MANUFACTURERS LIFE INSURANCE COMPANY, THE1,828,76701,828,76722,859,104Neu+100,0%
HSBC HOLDINGS PLC1,786,47001,786,47022,286,446Neu+100,0%
UBS Group AG1,747,24101,747,24121,753,151Neu+100,0%

Insider-Transaktionen (12 Monate)

DatumInsiderRolleTypStückzahlKursWert (USD)ΔTrend
2025-09-11Le Goff CorinneOfficer, Chief Commercial OfficerOpen Market Sale-7,03210.25-72,044.95-26,1%
2025-08-12Smith Scott AndrewDirector, Officer, Chief Executive OfficerOpen Market Purchase22,0009.99219,740.40+79,6%
2025-05-12Smith Scott AndrewDirector, Officer, Chief Executive OfficerOpen Market Purchase60,0008.94536,262.00+194,3%

Top-Fondshalter

Stand: 31.03.2026

FondsAnteileWert (USD)Anteil (%)
OPPENHEIMER & CO INC24,109325,713100.00

Hinweis

Erweitert ×